title: Structure and protein kinase C stimulating activities of lactam analogues of human parathyroid hormone fragment.
abstract: Five analogues of human parathyroid hormone (hPTH-(20-34)-NH2, I; cyclo[Lys26-Asp30]-hPTH-(20-34)-NH2, II; cyclo[Glu22-Lys26]-hPTH-(20-34)-NH2, III; cyclo[Lys27-Asp30]- hPTH-(20-34)-NH2, IV; and [Leu27]-hPTH-(20-34)-NH2 V) were tested for their ability to promote membrane-bound protein kinase C (PKC) activity in a rat osteosarcoma cell line (ROS 17/2). Analogues I, II and V stimulated PKC activity in the picomolar range, whereas analogues III and IV did not stimulate this activity at any concentration tested. The circular dichroism spectra in neutral, aqueous buffer showed an increase in alpha-helix in analogues II, III and V as compared to I; this increase appeared to be in the region of the cyclic lactam structure. Analogue IV did not adopt a helical structure, even in the presence of 40% trifluoroethanol, a helix-promoting solvent. The remaining analogues showed a three- to four-fold enhancement of alpha-helix in this solvent. Analogues II and III had increased retention times in reversed-phase chromatography, as compared to I and IV. This is consistent with a stabilization of amphiphilic helix in analogues II and III compared with I and IV. The data suggest that in the region bounded approximately by residues 24-32, an amphiphilic alpha-helix is important for correct functional binding to the PTH receptor.
authors.affiliation: Protein Structure and Function Section, National Research Council of Canada, Ottawa.
authors.forename: W
authors.initials: W
authors.lastname: Neugebauer
authors.forename: L
authors.initials: L
authors.lastname: Gagnon
authors.forename: J
authors.initials: J
authors.lastname: Whitfield
authors.forename: G E
authors.initials: GE
authors.lastname: Willick
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002845:Chromatography; D002942:Circular Dichroism; D006801:Humans; D007769:Lactams / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D008969:Molecular Sequence Data; D012516:Osteosarcoma / Q000188:drug therapy / Q000201:enzymology; D010281:Parathyroid Hormone / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D011493:Protein Kinase C / Q000187:drug effects* / Q000378:metabolism*; D017433:Protein Structure, Secondary; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D007769:Lactams; D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010456:Peptides, Cyclic; D011493:Protein Kinase C